Merck & Company Inc (MRK)

Frankfurt


	Symbol		Exchange		Currency
	MRK		NYSE		USD	Real-time
	0QAH		London		USD	Real-time
	MRK		Mexico		MXN	Delayed
	1MRKX		Milan		EUR	Real-time
	MRK		Xetra		EUR	Delayed
	MRK		TradeGate		EUR	Delayed
	MRK		Frankfurt		EUR	Delayed
	MRKm		Buenos Aires		ARS	Delayed
	MRCK34		B3		BRL	Delayed
	MRK		Vienna		EUR	Real-time
	MRK		Ukraine		UAH	Delayed
	MRK		Lima		USD	Delayed

Currency in EUR

Disclaimer

100.00

+0.20(+0.20%)

Closed04/10

Fair Value

Day's Range

99.60

100.20

52 wk Range

90.70

125.00

MRK Income Statement

Featured here, the Income Statement (earnings report) for Merck & Company Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

39,121

41,518

48,704

59,283

60,115

Total Revenues Growth

-7.5%

+6.13%

+17.31%

+21.72%

+1.4%

Cost Of Revenues

11,060

11,990

13,466

17,206

15,915

Gross Profit

28,061

29,528

35,238

42,077

44,200

Gross Profit Growth

-3.05%

+5.23%

+19.34%

+19.41%

+5.05%

Gross Profit Margin %

71.73%

71.12%

72.35%

70.98%

73.53%

Other Operating Expenses, Total

17,423

19,133

21,345

21,587

28,226

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-7.53%	+9.81%	+11.56%	+1.13%	+30.75%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,594	10,564	11,942	11,918	18,342
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,829	8,569	9,403	9,669	9,884
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

10,638

10,395

13,893

20,490

15,974

Operating Income Growth

+5.31%

-2.28%

+33.65%

+47.48%

-22.04%

EBIT Margin %

27.19%

25.04%

28.53%

34.56%

26.57%

Net Interest Expenses

-619

-713

-770

-805

-781

Net Interest Expenses Growth

-44.29%

-15.19%

-7.99%

-4.55%

+2.98%

Interest Expense, Total

-893

-831

-806

-962

-1,146

Interest And Investment Income

274

118

36

157

365

Other Non Operating Expenses, Total

-63

-74

-41

444

50

EBT, Excl. Unusual Items

9,956

9,608

13,082

20,129

15,243

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-133

-90

-275

-1,600

-1,352

EBT, Incl. Unusual Items

7,171

5,863

13,879

16,444

1,889

EBT, Incl. Unusual Items Growth

-17.58%

-18.24%

+136.72%

+18.48%

-88.51%

EBT, Incl. Unusual Items Margin

18.33

14.12

28.5

27.74

3.14

Income Tax Expense

1,565

1,340

1,521

1,918

1,512

Net Income to Company

9,759

7,071

13,062

14,526

377

Minority Interest

84

-4

-13

-7

-12

Net Income

9,843

7,067

13,049

14,519

365

Net Income Growth

+58.25%

-28.2%

+84.65%

+11.27%

-97.49%

Net Income Margin %

25.16%

17.02%

26.79%

24.49%

0.61%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

5,690

4,519

12,345

14,519

365

Basic EPS - Continuing Operations

2.22

1.79

4.88

5.73

0.14

Basic EPS - Continuing Operations Growth

-4.99%

-19.48%

+173.18%

+17.52%

-97.49%

Diluted EPS - Continuing Operations

2.21

1.78

4.86

5.71

0.14

Diluted EPS - Continuing Operations Growth

-4.74%

-19.46%

+173.03%

+17.49%

-97.55%

Basic Weighted Average Shares Outstanding

2,565

2,530

2,530

2,532

2,537

Diluted Weighted Average Shares Outstanding

2,580

2,541

2,538

2,542

2,547

Dividend Per Share

2.2

2.44

2.6

2.76

2.92

Dividend Per Share Growth

+14.58%

+10.91%

+6.56%

+6.15%

+5.8%

EBITDA

13,715

13,613

17,016

24,279

19,706

EBITDA Growth

-6.2%

-0.74%

+25%

+42.68%

-18.84%

EBITDA Margin %